Home
GRFS
GRFS News

Latest Grifols S.A. (GRFS) News on November 17, 2024

Banks to Pitch Roughly €11 Billion Buyout Debt for Grifols

Bloomberg

3 days ago

Banks to Pitch Roughly €11 Billion Buyout Debt for Grifols

Grifols SA (GIFLF) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Improved Cash ...

GuruFocus.com

9 days ago

Grifols SA (GIFLF) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Improved Cash ...

Morningstar Research

9 days ago

Analyst Report: Grifols, S.A.

MT Newswires

12 days ago

Market Chatter: Brookfield Asset Management Seeks Details of Grifols Related-Party Deals

Brookfield Seeks More Information on Grifols Related-Party Deals

Bloomberg

12 days ago

Brookfield Seeks More Information on Grifols Related-Party Deals

High Growth Tech Stocks to Watch in November 2024

Simply Wall St.

17 days ago

High Growth Tech Stocks to Watch in November 2024

Grifols And 2 Other Stocks That Might Be Trading Below Estimated Value

Simply Wall St.

18 days ago

Grifols And 2 Other Stocks That Might Be Trading Below Estimated Value

Grifols receives FDA approval to treat surgical bleeding with FS solution

TipRanks

18 days ago

Grifols receives FDA approval to treat surgical bleeding with FS solution

MT Newswires

19 days ago

Grifols's Fibrin Sealant Approved by FDA for Children; Shares Rise

Grifols Receives FDA Approval to Treat Surgical Bleeding in Pediatric Patients With its Fibrin Sealant Solution

GlobeNewswire

19 days ago

Grifols Receives FDA Approval to Treat Surgical Bleeding in Pediatric Patients With its Fibrin Sealant Solution

MT Newswires

a month ago

Grifols Teams Up With BARDA to Test Treatment for Eye Injuries Caused by Mustard Gas

Grifols Partners with BARDA for Proof-of-Concept Testing of Ocular Immunoglobulin as Treatment for Sulfur Mustard-Induced Eye Injury

GlobeNewswire

a month ago

Grifols Partners with BARDA for Proof-of-Concept Testing of Ocular Immunoglobulin as Treatment for Sulfur Mustard-Induced Eye Injury

MT Newswires

a month ago

Grifols Unit Wins US Government Contract to Develop Botulinum Neurotoxin Therapy

High Growth Tech Stocks To Watch In October 2024

Simply Wall St.

a month ago

High Growth Tech Stocks To Watch In October 2024

GigaGen Awarded U.S. BARDA Contract to Develop Recombinant Polyclonal Antibody Therapies for Botulinum Neurotoxins and an Additional Biothreat

GlobeNewswire

a month ago

GigaGen Awarded U.S. BARDA Contract to Develop Recombinant Polyclonal Antibody Therapies for Botulinum Neurotoxins and an Additional Biothreat

MT Newswires

2 months ago

Market Chatter: Brookfield Seeks More Time to Complete Due Diligence for Possible Grifols Takeover Bid

MT Newswires

2 months ago

Sector Update: Health Care Stocks Fall Late Afternoon

MT Newswires

2 months ago

Grifols Among Companies to Face Spanish Regulator's Disciplinary Proceedings

Grifols Investor Group With 7.7% Holding Seeks Seat on Board

Bloomberg

2 months ago

Grifols Investor Group With 7.7% Holding Seeks Seat on Board

MT Newswires

2 months ago

Sector Update: Health Care Stocks Rise Friday Afternoon

Orange, Grifols Egypt Team Up to Advance Egypt's Healthcare System

Zacks

2 months ago

Orange, Grifols Egypt Team Up to Advance Egypt's Healthcare System

MT Newswires

2 months ago

Market Chatter: Grifols Seeking Consultants to Fend off Shareholder Challenge

MT Newswires

2 months ago

Grifols Egypt Partners With Orange for Data Center, Communications Infrastructure

Grifols Holders Call on Family, Brookfield to Offer ‘Fair Price’

Bloomberg

2 months ago

Grifols Holders Call on Family, Brookfield to Offer ‘Fair Price’

Grifols Postpones Capital Markets Day Amid Potential Takeover

Bloomberg

2 months ago

Grifols Postpones Capital Markets Day Amid Potential Takeover

MT Newswires

3 months ago

Update: Market Chatter: Brookfield in Talks With Sovereign Funds to Join Grifols Acquisition Bid

MT Newswires

3 months ago

Market Chatter: Brookfield in Talks With Sovereign Funds to Join Grifols Acquisition Bid

Brookfield Courts Sovereign Funds to Join Grifols Takeover Bid

Bloomberg

3 months ago

Brookfield Courts Sovereign Funds to Join Grifols Takeover Bid

This Reviled Pharmaceutical Firm Holds Promise of a Healthier Future

The Wall Street Journal

3 months ago

This Reviled Pharmaceutical Firm Holds Promise of a Healthier Future

Why Grifols (GRFS) Stock Price Moved Up 7% on Wednesday

Zacks

3 months ago

Why Grifols (GRFS) Stock Price Moved Up 7% on Wednesday

MT Newswires

3 months ago

Sector Update: Health Care

Brookfield in talks with banks for funding Grifols' takeover bid, sources say

Reuters

3 months ago

Brookfield in talks with banks for funding Grifols' takeover bid, sources say

MT Newswires

3 months ago

European Equities Close Mostly Higher in Wednesday Trading; CMA Closes Probes Into Google, Apple

Brookfield Seeks Nearly €10 Billion to Back Grifols Takeover

Bloomberg

3 months ago

Brookfield Seeks Nearly €10 Billion to Back Grifols Takeover

Investing.com

3 months ago

Grifols shares up on potential takeover by Brookfield

Azvalor Iberia FI's Strategic Moves in Q2 2024: Spotlight on Linea Directa Aseguradora SA

GuruFocus.com

3 months ago

Azvalor Iberia FI's Strategic Moves in Q2 2024: Spotlight on Linea Directa Aseguradora SA

Associated Press Finance

4 months ago

Grifols: Q2 Earnings Snapshot

GigaGen Receives FDA Clearance of IND Application for Phase 1 Trial of Recombinant Polyclonal for HBV Treatment, GIGA-2339

GlobeNewswire

4 months ago

GigaGen Receives FDA Clearance of IND Application for Phase 1 Trial of Recombinant Polyclonal for HBV Treatment, GIGA-2339

Morningstar Research

4 months ago

Analyst Report: Grifols, S.A.

MT Newswires

4 months ago

Sector Update: Health Care Stocks Softer Tuesday Afternoon

MT Newswires

4 months ago

Market Chatter: Grifols Revises Financial Records Lower by $494 Million to Adjust Value Shanghai RAAS Stake

Grifols’ New Auditor Discovers Non-Cash Accounting Discrepancy Linked to China Stake

Bloomberg

4 months ago

Grifols’ New Auditor Discovers Non-Cash Accounting Discrepancy Linked to China Stake

MT Newswires

4 months ago

Grifols Gets US FDA Approval for Expanded Label of Xembify

Grifols receives expanded XEMBIFY® (immune globulin subcutaneous human-klhw) label in U.S., strengthening its Ig portfolio for patients

GlobeNewswire

4 months ago

Grifols receives expanded XEMBIFY® (immune globulin subcutaneous human-klhw) label in U.S., strengthening its Ig portfolio for patients

Three Stocks Estimated To Be Trading With Intrinsic Discounts Between 35.9% And 49.7%

Simply Wall St.

4 months ago

Three Stocks Estimated To Be Trading With Intrinsic Discounts Between 35.9% And 49.7%

Grifols Family Shareholders, Brookfield in Talks To Take Firm Private

Investopedia

4 months ago

Grifols Family Shareholders, Brookfield in Talks To Take Firm Private

MT Newswires

4 months ago

Grifols Shares Surge on Take-Private Talks

MT Newswires

4 months ago

European Equities Close Mixed in Monday Trading

Morningstar Research

4 months ago

Analyst Report: Grifols, S.A.

Beleaguered Spanish Drug Firm Grifols Stock Jumps On Monday - Here's Why

Benzinga

4 months ago

Beleaguered Spanish Drug Firm Grifols Stock Jumps On Monday - Here's Why

MT Newswires

4 months ago

Market Chatter: Grifols Says Founding Family, Brookfield Weigh Takeover Bid

Grifols Says Founding Family, Brookfield Weigh Takeover Bid

Bloomberg

4 months ago

Grifols Says Founding Family, Brookfield Weigh Takeover Bid

MT Newswires

4 months ago

Sector Update: Health Care

MT Newswires

4 months ago

Grifols Appoints New Chief Financial Officer

Grifols’ Biotest to achieve USD 1 billion in US sales of Yimmugo® over next seven years

GlobeNewswire

5 months ago

Grifols’ Biotest to achieve USD 1 billion in US sales of Yimmugo® over next seven years

Grifols Leads Three Stocks That May Be Priced Below Their Estimated True Value

Simply Wall St.

5 months ago

Grifols Leads Three Stocks That May Be Priced Below Their Estimated True Value

Grifols completes sale of a 20% equity stake in SRAAS and forges strategic alliance with Haier Group

GlobeNewswire

5 months ago

Grifols completes sale of a 20% equity stake in SRAAS and forges strategic alliance with Haier Group

Biotest wins FDA approval for plasma protein therapy

Pharmaceutical Technology

5 months ago

Biotest wins FDA approval for plasma protein therapy

Grifols prepares for late-stage plans with plasma-derived medicines in 2024

Pharmaceutical Technology

5 months ago

Grifols prepares for late-stage plans with plasma-derived medicines in 2024

MT Newswires

5 months ago

Grifols' Biotest Gets FDA Approval for Yimmugo

Grifols’ Biotest receives FDA approval for innovative Yimmugo® immunoglobulin to treat primary immunodeficiencies

GlobeNewswire

5 months ago

Grifols’ Biotest receives FDA approval for innovative Yimmugo® immunoglobulin to treat primary immunodeficiencies

Morningstar Research

5 months ago

Analyst Report: Grifols, S.A.

GigaGen doses first subject in Phase I advanced solid tumour trial

Clinical Trials Arena

6 months ago

GigaGen doses first subject in Phase I advanced solid tumour trial

Morningstar Research

6 months ago

Analyst Report: Grifols, S.A.

Short Seller Gains on Grifols Bet That Tripped Elliott Spinout

Bloomberg

6 months ago

Short Seller Gains on Grifols Bet That Tripped Elliott Spinout

MT Newswires

6 months ago

Grifols Shares Rise as Haier Deal Set to Close in June

Grifols 2023 Annual Report on Form 20-F filed with the SEC

PR Newswire

7 months ago

Grifols 2023 Annual Report on Form 20-F filed with the SEC

Grifols Celebrates 50 Years of Manufacturing Life-Changing Plasma-Derived Medicines for Patients at Flagship Site in Clayton, N.C.

GlobeNewswire

7 months ago

Grifols Celebrates 50 Years of Manufacturing Life-Changing Plasma-Derived Medicines for Patients at Flagship Site in Clayton, N.C.

Spanish drug maker Grifols will bring in independent directors, chairman tells newspaper

Reuters

7 months ago

Spanish drug maker Grifols will bring in independent directors, chairman tells newspaper

Grifols Plans First Bond Sale Since Short Seller Attack

Bloomberg

7 months ago

Grifols Plans First Bond Sale Since Short Seller Attack

Grifols Procleix ArboPlex Assay® Receives CE Mark, the First and Only 4-in-1 NAT for Arbovirus Screening

GlobeNewswire

7 months ago

Grifols Procleix ArboPlex Assay® Receives CE Mark, the First and Only 4-in-1 NAT for Arbovirus Screening

Grifols Drops as Regulator Finds ‘Relevant Deficiencies’

Bloomberg

8 months ago

Grifols Drops as Regulator Finds ‘Relevant Deficiencies’

Morningstar Research

8 months ago

Analyst Report: Grifols, S.A.

Health Care Roundup: Market Talk

The Wall Street Journal

8 months ago

Health Care Roundup: Market Talk

Reuters

8 months ago

UPDATE 2-Europe's STOXX 600 logs weekly gains, US jobs data in focus

Morningstar Research

8 months ago

Analyst Report: Grifols, S.A.

Spanish Healthcare Firm Grifols Hit With New Gotham City's Short Report, Faces Questions Regarding Transparency, Integrity, Ethical Conduct

Benzinga

8 months ago

Spanish Healthcare Firm Grifols Hit With New Gotham City's Short Report, Faces Questions Regarding Transparency, Integrity, Ethical Conduct

Morningstar Research

9 months ago

Analyst Report: Grifols, S.A.

Grifols Drops 35% as Management Flags Risk of Zero Cash Flow

Bloomberg

9 months ago

Grifols Drops 35% as Management Flags Risk of Zero Cash Flow

Activists Load Up on Temenos, Grifols After Short Seller Reports

Bloomberg

9 months ago

Activists Load Up on Temenos, Grifols After Short Seller Reports

GRFS or ZTS: Which Is the Better Value Stock Right Now?

Zacks

9 months ago

GRFS or ZTS: Which Is the Better Value Stock Right Now?

Grifols announces positive topline phase 3 fibrinogen clinical trial results

GlobeNewswire

9 months ago

Grifols announces positive topline phase 3 fibrinogen clinical trial results

Charles Brandes Adjusts Position in Grifols SA

GuruFocus.com

9 months ago

Charles Brandes Adjusts Position in Grifols SA

Charles Brandes Bolsters Position in Grifols SA

GuruFocus.com

9 months ago

Charles Brandes Bolsters Position in Grifols SA

Here's Why Grifols (GRFS) Is a Great 'Buy the Bottom' Stock Now

Zacks

9 months ago

Here's Why Grifols (GRFS) Is a Great 'Buy the Bottom' Stock Now

Another sneaky Biden energy move

Yahoo Finance

10 months ago

Another sneaky Biden energy move

GRFS or ZTS: Which Is the Better Value Stock Right Now?

Zacks

10 months ago

GRFS or ZTS: Which Is the Better Value Stock Right Now?

Navigating Market Uncertainty: Intrinsic Value of The Home Depot Inc

GuruFocus.com

10 months ago

Navigating Market Uncertainty: Intrinsic Value of The Home Depot Inc

Reuters

10 months ago

UPDATE 1-Spain's Grifols sues Gotham City fund, JV over damaging report

Grifols Sues Gotham City Over ‘False’ Short-Seller Report

Bloomberg

10 months ago

Grifols Sues Gotham City Over ‘False’ Short-Seller Report

Reuters

10 months ago

Spain's Grifols sues Gotham City fund, JV over damaging report

BP Eyes FID for Trinidad's Calypso Deepwater Gas Field by 2025

Zacks

10 months ago

BP Eyes FID for Trinidad's Calypso Deepwater Gas Field by 2025

The Return Trends At Fluor (NYSE:FLR) Look Promising

Simply Wall St.

10 months ago

The Return Trends At Fluor (NYSE:FLR) Look Promising

Robinhood Markets, Inc. (HOOD) Stock Dips While Market Gains: Key Facts

Zacks

10 months ago

Robinhood Markets, Inc. (HOOD) Stock Dips While Market Gains: Key Facts

Will Gentex (GNTX) Beat Estimates Again in Its Next Earnings Report?

Zacks

10 months ago

Will Gentex (GNTX) Beat Estimates Again in Its Next Earnings Report?

Reuters

10 months ago

UPDATE 1-Cleveland-Cliffs argued its US Steel bid was worth more than Nippon Steel's, filing shows

Cleveland-Cliffs argued its US Steel bid was worth more than Nippon Steel's, filing shows

Reuters

10 months ago

Cleveland-Cliffs argued its US Steel bid was worth more than Nippon Steel's, filing shows

Health Care Roundup: Market Talk

The Wall Street Journal

10 months ago

Health Care Roundup: Market Talk

Core & Main Announces Secondary Offering and Share Repurchase

Business Wire

10 months ago

Core & Main Announces Secondary Offering and Share Repurchase

WYNDHAM COMMENTS ON CHOICE'S SELF-SERVING DIRECTOR NOMINATIONS

PR Newswire

10 months ago

WYNDHAM COMMENTS ON CHOICE'S SELF-SERVING DIRECTOR NOMINATIONS

Share on Social Networks: